Scinai Immunotherapeutics (SCNI) Cash from Operations Growth (1y) (2019 - 2026)
Scinai Immunotherapeutics (SCNI) Cash from Operations Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 7.14% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 356.73% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 74.39% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 3.23% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Scinai Immunotherapeutics | 3.74 Bn | 624.08 Mn | -1.12 Mn | -39.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.87% |
| Jun 30, 2025 | 12.74% |
| Mar 31, 2025 | 28.84% |
| Dec 31, 2024 | 12.16% |
| Sep 30, 2024 | 8.28% |
| Jun 30, 2024 | 38.87% |
| Mar 31, 2024 | 52.17% |
| Dec 31, 2023 | -106.58% |
| Sep 30, 2023 | -16.82% |
| Jun 30, 2023 | 21.53% |
| Mar 31, 2023 | -176.83% |
| Dec 31, 2022 | 68.17% |
| Sep 30, 2022 | 69.26% |
| Jun 30, 2022 | 53.67% |
| Mar 31, 2022 | 4.74% |
| Dec 31, 2021 | 88.29% |
| Sep 30, 2021 | 40.00% |
| Jun 30, 2021 | 33.19% |
| Mar 31, 2019 | -41.49% |